What is the Prostate Specific Antigen Cut-off Value to Detect Metastases in Ga-68 Prostate Specific Membrane Antigen Ligand Positron Emission Tomography/ Computer Tomography Imaging for Intermediate and High-risk Prostate Cancer?
Journal Title: The Bulletin of Urooncology - Year 2020, Vol 19, Issue 3
Abstract
Objective: The aim of this study was to detect a prostate specific antigen (PSA) cut-off value for metastases, and prevent unnecessary use of Ga-68 prostate specific membrane antigen (PSMA) ligand positron emission tomography/computer tomography (CT) imaging. Materials and Methods: Between January 2016 and October 2017, patients with prostate cancer (PCa) who were staged using Ga-68 PSMA enrolled in this retrospective study. Patients were divided into two groups: group 1 (G1) had Ga-68 PSMA for primary staging, and group 2 (G2) had Ga-68 PSMA for detection of metastases after treatment (secondary staging). PSA cut-off values were calculated for general, bone, lymph node and visceral metastases. Results: A total of 181 patients were included in this study. PSA cut-off was 7.5 ng/mL for overall metastases in general. The PSA cut-offs for overall metastases using initial PSA were 8.98 ng/mL and 6.82 ng/mL for G1 and G2, respectively. For G2 patients the post-treatment PSA cut-off was 0.38 ng/mL. For bone metastases, the PSA cut-offs using initial PSA were 8.98 ng/mL and 10.7 ng/mL for G1 and G2, respectively. For lymph node metastases, the PSA cut-offs using initial PSA were 8.98 ng/mL and 6.71 ng/mL for G1 and G2, respectively. For visceral metastases, the PSA cut-offs using initial PSA were 16.4 ng/mL and 7.08 ng/ mL for G1 and G2, respectively. The same analyses could not be calculated in subgroups of G2 due to small sample size. Conclusion: These cut-off values do not suggest that Ga-68 PSMA is superior to using both CT and bone scintigraphy. It is an expensive test and its use is only reasonable when small lymph node metastases cannot be evaluated in CT.
Authors and Affiliations
Burak Köprü, Turgay Ebiloğlu, Engin Kaya, Engin Alagöz, Murat Zor, Mustafa Özdeş Emer, Mesut Gürdal, Selahattin Bedir, Nuri Arslan
Keywords
Related Articles
- EP ID EP688793
- DOI 10.4274/uob.galenos.2020.1499
- Views 135
- Downloads 0
Evaluation of General Features of Patients with Testicular Cancer
Objective: Testicular cancers (Tca) are most common in men aged 20-34. Despite the increase in its incidence, the mortality rate from Tca decreases. In our study, it was aimed to evaluate the general characteristics, the...
Comparison of Three Different Antibiotic Protocols Used as Prostate Biopsy Prophylaxis in Terms of Infectious Complications
Objective: Development of urinary infection and sepsis following prostate biopsy procedure is the main problem. Despite use of antibiotic prophylaxis, which becomes a routine procedure in prostate biopsy, urinary infecti...
Current Approach in Radiation Therapy for Prostate Cancer
Prostate cancer is one of the most common malignancies in men. Radiotherapy is one of the main treatment modalities in the treatment of prostate cancer. The reflection of technological advances in the field of radiation...
“Atypical Cell’’ Parameter in Automated Urine Analysis for the Diagnosis of Bladder Cancer: A Retrospective Pilot Study
Objective: To evaluate the application of an automated urine analyzer (AUA) for the diagnosis of bladder cancer (BC). Materials and Methods: A retrospective data analysis of 2365 urine specimens from the department of u...
Influence of Primary or Secondary Muscle Invasive Bladder Cancer on Oncologic Outcomes After Radical Cystectomy
Objective: In this study, we aimed to investigate the oncologic outcomes of patients who were diagnosed with primary (muscle invasive cancer at the time of diagnosis) and secondary (cancer that showed progression from no...